Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Brain Neoplasms × Patient Reported Outcome Measures × 90 days × Clear all

Sponsor

Conditions

Preleukemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoproliferative Disorders 2 Lymphoma 2 Lymphatic Diseases 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Leukemia 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Diseases 2 Bone Marrow Diseases 2 Primary Myelofibrosis 1 Pathologic Complete Response 1 Myeloproliferative Disorders 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Chronic 1 Breast Neoplasms 1

Interventions

Radiosurgery 24 Magnetic Resonance Spectroscopy 19 Temozolomide 14 Specimen Handling 9 Radiotherapy 9 Cyclophosphamide 9 pembrolizumab 7 Bevacizumab 7 abemaciclib 6 trastuzumab deruxtecan 5 Nivolumab 5 Ipilimumab 5 Etoposide 5 Carboplatin 5 Radiation 4 Biopsy 4 fludarabine 3 entrectinib 3 X-Rays 3 Trastuzumab 3 Mental Status and Dementia Tests 3 Dexamethasone 3 Capecitabine 3 Blood Specimen Collection 3 niraparib 2 etoposide phosphate 2 cabozantinib 2 aflutinib 2 Topotecan 2 Surveys and Questionnaires 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡